Tengjun Biotechnology Corp. Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31)
Tengjun Biotechnology Corp. had Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) of $232.60 thousand as of 2014-12-31, per its 10-K filed 2015-04-14.
Discontinued › Notes
us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage · last filed 2015-04-14
- 2014-12-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $232.60K.
- 2014-09-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $220.89K.
- 2014-06-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $189.06K.
- 2014-03-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $182.42K.
| Period end | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) as first filed |
|---|---|---|
| 2014-12-31 | $232.60K 10-K · filed 2015-04-14 | |
| 2014-09-30 | $220.89K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $189.06K 10-Q · filed 2014-08-19 | |
| 2014-03-31 | $182.42K 10-Q · filed 2014-06-04 | |
| 2013-12-31 | $124.23K 10-K · filed 2015-04-14 | -$124.23K 10-K · filed 2014-04-09 |
| 2013-09-30 | $107.92K 10-Q · filed 2013-11-19 | |
| 2013-06-30 | $106.92K 10-Q · filed 2013-08-13 | |
| 2013-03-31 | -$105.92K 10-Q · filed 2013-05-16 | |
| 2012-12-31 | -$102.92K 10-K · filed 2014-04-09 | |
| 2012-09-30 | -$102.92K 10-Q · filed 2012-11-15 | |
| 2012-06-30 | -$95.76K 10-Q/A · filed 2012-08-09 | |
| 2011-12-31 | $68.75K 10-K/A · filed 2013-05-10 | -$68.75K 10-Q/A · filed 2012-08-09 |
| 2011-06-30 | -$60.42K 10-Q/A · filed 2011-08-19 | |
| 2010-12-31 | -$43.99K 10-Q/A · filed 2011-08-19 |